查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375934

泌尿系統肉毒桿菌毒素市場規模、佔有率和趨勢分析報告：按應用、最終用途、地區和細分市場預測，2023-2030 年

Botulinum Toxin In Urology Market Size, Share & Trends Analysis Report By Application (Overactive Bladder, Neurogenic Detrusor Overactivity), By End-use (Hospitals, Urology Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

肉毒桿菌毒素市場成長與泌尿系統趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球泌尿系統肉毒桿菌市場預計將達到 14.5 億美元。

預計 2023 年至 2030 年該市場將以 6.0% 的年複合成長率成長。由於神經源性膀胱的盛行率不斷上升，以及與泌尿狀況問題和尿失禁相關的老年人口不斷增加，對肉毒桿菌毒素的需求不斷成長。例如，根據 2020 年美國人口普查局的數據，2023 年 5 月，約有 5,580 萬人，即美國人口的 16.8%，被歸類為老年人。因此，老年人口的增加導致泌尿系統疾病問題的增加，進一步導致市場成長。

根據澳洲失禁基金會 2023 年 5 月的數據，澳洲約 38% 的女性和 10% 的男性患有尿失禁。因此，尿失禁盛行率的增加推動了市場的成長。尿失禁的原因包括便秘、骨盆底疾病、中風和某些藥物的副作用。

然而，政府和私人組織增加對研發的投資，探索泌尿系統肉毒桿菌的治療方法，正在為市場創造新的機會。例如，2022 年 7 月，艾伯維公司 (AbbVie Inc.) 和艾爾建 PLC (Allergan PLC) 在新奧爾良舉行的 TOXINS 2022 大會上進行了 30 多場演講，其中包括 7 場講台演講。其中重點介紹了 A 型肉毒桿菌毒素的臨床前研究、臨床研究和實際使用資料。因此，來自不同機構的資金增加正在推動市場成長。

泌尿系統市場報告亮點中的肉毒桿菌毒素

  • 從應用來看，膀胱過動症細分市場預計將在 2022 年佔據最大的市場佔有率，達到 67.14%，並在預測期內實現最快的年複合成長率。腹部創傷、過量飲酒和神經損傷等因素會增加膀胱過動症的發生率，進一步加劇該節段的生長。
  • 按最終用途分類，醫院細分市場佔據最大市場佔有率，2022 年將達到 73.74%。新興市場的醫院數量不斷增加和技術進步正在推動該領域的市場成長。
  • 北美地區成為市場領先地區，2022 年佔最大佔有率，達 37.41%。該地區強大的醫療基礎設施、熟練的醫療專業人員和先進的醫療設施促進了該地區的市場成長。
  • 由於慢性病和糖尿病盛行率不斷上升，預計亞太地區在預測期內的複合年複合成長率將達到 7.3%。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系展望
  • 市場趨勢及展望
  • 市場動態
  • 市場抑制因素分析
  • 營商環境分析
  • 經濟影響分析

第4章 應用業務分析

  • 泌尿系統市場中的肉毒桿菌毒素，按應用分：要點
  • 泌尿系統市場肉毒桿菌：2022年和2030年應用趨勢和市場佔有率分析
  • 膀胱過動症
    • 2018-2030 年全球膀胱過動症市場估計與預測
  • 神經源性逼尿肌過度活動
    • 2018-2030 年全球神經源性逼尿肌過度活動市場估計與預測

第5章 最終用途業務分析

  • 泌尿系統肉毒桿菌毒素市場（依最終用途）：重點
  • 泌尿系統肉毒桿菌毒素市場：2022 年和 2030 年最終用途趨勢和市場佔有率分析
  • 醫院
  • 泌尿系統診所

第6章 區域業務分析

  • 區域市場簡介
  • 北美洲
    • 北美泌尿系統肉毒桿菌毒素市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲泌尿系統肉毒桿菌毒素市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區泌尿系統肉毒桿菌市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲泌尿系統肉毒桿菌市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東及非洲泌尿系統肉毒桿菌市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 公司簡介/名單
    • AbbVie Inc.
    • Merz Pharma
    • Ipsen Pharma
    • GALDERMA
    • Allergan PLC
    • Sun Pharmaceutical Industries Ltd.
    • Biovencer Healthcare Pvt Ltd
Product Code: GVR-4-68040-138-5

Botulinum Toxin In Urology Market Growth & Trends:

The global botulinum toxin in urology market size is anticipated to reach USD 1.45 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 6.0% from 2023 to 2030. The demand for botulinum toxin is growing due to a rise in the prevalence of neurogenic bladder, rising geriatric population associated with urinary condition problems and urinary incontinence. For instance, in May 2023, according to the U.S. Census Bureau 2020, around 55.8 million or 16.8% of the population in the U.S. has been classified as older. As a result, the rising geriatric population has led to an increase in urinary condition problems, further leading to market growth.

In addition, in May 2023, according to the Continence Foundation of Australia, urinary incontinence affects about 38% of women and 10% of men in Australia. Thus, the increase in the prevalence of urinary incontinence raised the growth of the market. Urinary incontinence is caused due to constipation, pelvic floor disorders, stroke, and side effects of certain medications.

However, rising investment in R&D by government and private organizations to explore the therapeutic approach of botulinum in the urology sector creates new opportunities for the market. For instance, in July 2022, AbbVie Inc. and Allergan PLC presented more than 30 abstracts, including seven podium presentations at the TOXINS 2022 Conference in New Orleans. It highlighted preclinical research, clinical studies, and real-world utilization data of onabotulinumtoxinA. Thus, increased funding by various institutions boosts market growth.

Botulinum Toxin In Urology Market Report Highlights:

  • In terms of application, the overactive bladder segment held the largest market share of 67.14% in 2022 and it is anticipated to register the fastest CAGR over the forecast period. Factors such as abdominal trauma, excessive alcohol consumption, and nerve damage increase the incidence of overactive bladder, further increasing the segment's growth
  • Based on end-use, the hospitals segment held the largest market share of 73.74% in 2022. The growing number of hospitals in developing nations and technological advancements are fueling the market growth of this segment
  • North America region emerged as the leading market region in 2022, holding the largest share of 37.41%. The region's robust healthcare infrastructure, skilled healthcare professionals, and advanced medical facilities contribute to the market growth in the region.
  • The Asia Pacific region is anticipated to register the fastest CAGR of 7.3% over the forecast period owing to the increased prevalence of chronic diseases and diabetes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Commodity Flow Analysis
      • 1.5.1.1. Approach 1: Commodity flow approach
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Restraint Analysis
  • 3.5. Business Environment Analysis
    • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.5.2. Porter's Five Forces Analysis
  • 3.6. Economic Impact Analysis

Chapter 4. Application Business Analysis

  • 4.1. Botulinum Toxin In Urology Market, By Application: Key Takeaways
  • 4.2. Botulinum Toxin In Urology Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Overactive Bladder
    • 4.3.1. Global Overactive Bladder Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Neurogenic Detrusor Overactivity
    • 4.4.1. Global Neurogenic Detrusor Overactivity Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Botulinum Toxin In Urology Market, By End-use: Key Takeaways
  • 5.2. Botulinum Toxin In Urology Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Global Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Urology Clinics
    • 5.4.1. Global Urology Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Germany Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. UK Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. AbbVie Inc.
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Merz Pharma
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Ipsen Pharma
      • 7.3.3.1. Overview
      • 7.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.3.3. Product Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. GALDERMA
      • 7.3.4.1. Overview
      • 7.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.4.3. Product Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Allergan PLC
      • 7.3.5.1. Overview
      • 7.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.5.3. Product Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Sun Pharmaceutical Industries Ltd.
      • 7.3.6.1. Overview
      • 7.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.6.3. Product Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Biovencer Healthcare Pvt Ltd
      • 7.3.7.1. Overview
      • 7.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.7.3. Product Benchmarking
      • 7.3.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 3 Global Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Botulinum Toxin In Urology Market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America Botulinum Toxin In Urology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 9 U.S. Botulinum Toxin In Urology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Botulinum Toxin In Urology Market, by End-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 16 Germany Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 20 France Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Italy Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 24 Spain Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 28 Sweden Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 30 Norway Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 China Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 35 China Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Japan Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 39 India Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Australia Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 45 Thailand Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America Botulinum Toxin In Urology Market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 48 Latin America Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 50 Brazil Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 52 Mexico Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 54 Argentina Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Africa Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 UAE Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 62 UAE Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Botulinum Toxin In Urology Market, by application, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Botulinum Toxin In Urology Market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Botulinum Toxin In Urology Market Segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's Five Forces analysis
  • Fig. 14 Global Botulinum Toxin In Urology Market: Application Outlook Key Takeaways
  • Fig. 15 Global Botulinum Toxin In Urology Market: Application Movement Analysis
  • Fig. 16 Global Overactive Bladder Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global Neurogenic Detrusor Overactivity Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Botulinum Toxin In Urology Market: End-use Outlook Key Takeaways
  • Fig. 19 Global Botulinum Toxin In Urology Market: End-use Movement Analysis
  • Fig. 20 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Urology Clinics Market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional Marketplace: Key Takeaways
  • Fig. 23 Regional Outlook, 2022 & 2030
  • Fig. 24 Global Botulinum Toxin In Urology Market: Region Movement Analysis
  • Fig. 25 North America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 30 UK Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 31 France Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 40 China Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 41 India Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Botulinum Toxin In Urology Market, 2018 - 2030 (USD Million)